A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

No patients died of prostate cancer. The 5-year overall survival was 90%.

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

September 26, 2025New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and ...

Prostatectomy and radiation therapy show no survival difference for low-risk prostate cancer, but higher-risk cases require careful treatment consideration. The ProtecT trial supports active ...

At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

Dr. Adam Dicker answers the question: 'Urinary Impact of Radiation Therapy?' March 16, 2009 -- Question: What are the urinary impacts of radiation therapy for prostate cancer, and how do they compare ...

Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...

SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer. The utility of SpaceOAR Hydrogel, a polyethylene ...

Dr. Kalnicki answers the question: 'Is Prostate Surgery Done After Radiation?' March 16, 2009 -- Question: Can I have prostate surgery if my radiation treatments are unsuccessful? Answer: Prostate ...